E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/1/2006 in the Prospect News Biotech Daily.

Stressgen changes name to Nventa

New York, June 1 - Stressgen Biotechnologies Corp. said it has changed its name to Nventa Biopharmaceuticals Corp.

The stock will start trading on the Toronto Stock Exchange under the new symbol "NVN" on June 7. The current ticker is "SSB."

Based in San Diego, Nventa/Stressgen is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.